 | • レポートコード：GIR-107A14299 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、注射可能ドラッグデリバリー製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。注射可能ドラッグデリバリー製剤の種類別市場規模（従来型ドラッグデリバリー製剤、新型ドラッグデリバリー製剤、長時間作用型製剤）、用途別市場規模（自己免疫疾患、ホルモン性疾患、腫瘍、希少疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・注射可能ドラッグデリバリー製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Becton, Dickinson and Company (US)、Baxter International Inc. (US)、Gerresheimer AG (Germany)、Pfizer, Inc. (US)、Schott AG (Germany)、Sandoz (Germany)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (US) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：従来型ドラッグデリバリー製剤、新型ドラッグデリバリー製剤、長時間作用型製剤 ・用途別分析2016年-2026年：自己免疫疾患、ホルモン性疾患、腫瘍、希少疾患、その他 ・注射可能ドラッグデリバリー製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・注射可能ドラッグデリバリー製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・注射可能ドラッグデリバリー製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・注射可能ドラッグデリバリー製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・注射可能ドラッグデリバリー製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Injectable Drug Delivery Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Injectable Drug Delivery Formulation size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Injectable Drug Delivery Formulation market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Injectable Drug Delivery Formulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations
Market segment by Application can be divided into
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others
The key market players for global Injectable Drug Delivery Formulation market are listed below:
Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Injectable Drug Delivery Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Drug Delivery Formulation, with price, sales, revenue and global market share of Injectable Drug Delivery Formulation from 2019 to 2021.
Chapter 3, the Injectable Drug Delivery Formulation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Drug Delivery Formulation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Injectable Drug Delivery Formulation market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Injectable Drug Delivery Formulation sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Injectable Drug Delivery Formulation Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Drug Delivery Formulation Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Conventional Drug Delivery Formulations
1.2.3 Novel Drug Delivery Formulations
1.2.4 Long-acting Formulations
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Drug Delivery Formulation Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Autoimmune Diseases
1.3.3 Hormonal Disorders
1.3.4 Oncology
1.3.5 Orphan Diseases
1.3.6 Others
1.4 Global Injectable Drug Delivery Formulation Market Size & Forecast
1.4.1 Global Injectable Drug Delivery Formulation Sales in Value (2016-2026))
1.4.2 Global Injectable Drug Delivery Formulation Sales in Volume (2016-2026)
1.4.3 Global Injectable Drug Delivery Formulation Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Injectable Drug Delivery Formulation Production Capacity Analysis
1.5.1 Global Injectable Drug Delivery Formulation Total Production Capacity (2016-2026)
1.5.2 Global Injectable Drug Delivery Formulation Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Drug Delivery Formulation Market Drivers
1.6.2 Injectable Drug Delivery Formulation Market Restraints
1.6.3 Injectable Drug Delivery Formulation Trends Analysis
2 Manufacturers Profiles
2.1 Becton, Dickinson and Company (US)
2.1.1 Becton, Dickinson and Company (US) Details
2.1.2 Becton, Dickinson and Company (US) Major Business
2.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product and Services
2.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Baxter International Inc. (US)
2.2.1 Baxter International Inc. (US) Details
2.2.2 Baxter International Inc. (US) Major Business
2.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product and Services
2.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Gerresheimer AG (Germany)
2.3.1 Gerresheimer AG (Germany) Details
2.3.2 Gerresheimer AG (Germany) Major Business
2.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product and Services
2.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer, Inc. (US)
2.4.1 Pfizer, Inc. (US) Details
2.4.2 Pfizer, Inc. (US) Major Business
2.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product and Services
2.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Schott AG (Germany)
2.5.1 Schott AG (Germany) Details
2.5.2 Schott AG (Germany) Major Business
2.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Product and Services
2.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sandoz (Germany)
2.6.1 Sandoz (Germany) Details
2.6.2 Sandoz (Germany) Major Business
2.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Product and Services
2.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Teva Pharmaceutical Industries Ltd. (Israel)
2.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Details
2.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Major Business
2.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Eli Lilly and Company (US)
2.8.1 Eli Lilly and Company (US) Details
2.8.2 Eli Lilly and Company (US) Major Business
2.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product and Services
2.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Injectable Drug Delivery Formulation Sales by Manufacturer
3.1 Global Injectable Drug Delivery Formulation Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Injectable Drug Delivery Formulation Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Injectable Drug Delivery Formulation
3.4 Market Concentration Rate
3.4.1 Top 3 Injectable Drug Delivery Formulation Manufacturer Market Share
3.4.2 Top 6 Injectable Drug Delivery Formulation Manufacturer Market Share
3.5 Global Injectable Drug Delivery Formulation Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Injectable Drug Delivery Formulation Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Injectable Drug Delivery Formulation Market Size by Region
4.1.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region (2016-2026)
4.1.2 Global Injectable Drug Delivery Formulation Revenue by Region (2016-2026)
4.2 North America Injectable Drug Delivery Formulation Revenue (2016-2026)
4.3 Europe Injectable Drug Delivery Formulation Revenue (2016-2026)
4.4 Asia-Pacific Injectable Drug Delivery Formulation Revenue (2016-2026)
4.5 South America Injectable Drug Delivery Formulation Revenue (2016-2026)
4.6 Middle East and Africa Injectable Drug Delivery Formulation Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Injectable Drug Delivery Formulation Sales in Volume by Type (2016-2026)
5.2 Global Injectable Drug Delivery Formulation Revenue by Type (2016-2026)
5.3 Global Injectable Drug Delivery Formulation Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Injectable Drug Delivery Formulation Sales in Volume by Application (2016-2026)
6.2 Global Injectable Drug Delivery Formulation Revenue by Application (2016-2026)
6.3 Global Injectable Drug Delivery Formulation Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Injectable Drug Delivery Formulation Sales by Type (2016-2026)
7.2 North America Injectable Drug Delivery Formulation Sales by Application (2016-2026)
7.3 North America Injectable Drug Delivery Formulation Market Size by Country
7.3.1 North America Injectable Drug Delivery Formulation Sales in Volume by Country (2016-2026)
7.3.2 North America Injectable Drug Delivery Formulation Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Injectable Drug Delivery Formulation Sales by Type (2016-2026)
8.2 Europe Injectable Drug Delivery Formulation Sales by Application (2016-2026)
8.3 Europe Injectable Drug Delivery Formulation Market Size by Country
8.3.1 Europe Injectable Drug Delivery Formulation Sales in Volume by Country (2016-2026)
8.3.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2016-2026)
9.2 Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2016-2026)
9.3 Asia-Pacific Injectable Drug Delivery Formulation Market Size by Region
9.3.1 Asia-Pacific Injectable Drug Delivery Formulation Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Injectable Drug Delivery Formulation Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Injectable Drug Delivery Formulation Sales by Type (2016-2026)
10.2 South America Injectable Drug Delivery Formulation Sales by Application (2016-2026)
10.3 South America Injectable Drug Delivery Formulation Market Size by Country
10.3.1 South America Injectable Drug Delivery Formulation Sales in Volume by Country (2016-2026)
10.3.2 South America Injectable Drug Delivery Formulation Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2016-2026)
11.2 Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2016-2026)
11.3 Middle East & Africa Injectable Drug Delivery Formulation Market Size by Country
11.3.1 Middle East & Africa Injectable Drug Delivery Formulation Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Injectable Drug Delivery Formulation Typical Distributors
12.3 Injectable Drug Delivery Formulation Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Injectable Drug Delivery Formulation Revenue by Type, (USD Million), 2021-2026
Table 2. Global Injectable Drug Delivery Formulation Revenue by Application, (USD Million), 2021-2026
Table 3. Becton, Dickinson and Company (US) Basic Information, Manufacturing Base and Competitors
Table 4. Becton, Dickinson and Company (US) Major Business
Table 5. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product and Services
Table 6. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Baxter International Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 8. Baxter International Inc. (US) Major Business
Table 9. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product and Services
Table 10. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Gerresheimer AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 12. Gerresheimer AG (Germany) Major Business
Table 13. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product and Services
Table 14. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer, Inc. (US) Major Business
Table 17. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product and Services
Table 18. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Schott AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Schott AG (Germany) Major Business
Table 21. Schott AG (Germany) Injectable Drug Delivery Formulation Product and Services
Table 22. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sandoz (Germany) Basic Information, Manufacturing Base and Competitors
Table 24. Sandoz (Germany) Major Business
Table 25. Sandoz (Germany) Injectable Drug Delivery Formulation Product and Services
Table 26. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical Industries Ltd. (Israel) Major Business
Table 29. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product and Services
Table 30. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Eli Lilly and Company (US) Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly and Company (US) Major Business
Table 33. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product and Services
Table 34. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Injectable Drug Delivery Formulation Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Injectable Drug Delivery Formulation Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Injectable Drug Delivery Formulation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Injectable Drug Delivery Formulation Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Injectable Drug Delivery Formulation Production Site of Key Manufacturer
Table 40. Injectable Drug Delivery Formulation New Entrant and Capacity Expansion Plans
Table 41. Injectable Drug Delivery Formulation Mergers & Acquisitions in the Past Five Years
Table 42. Global Injectable Drug Delivery Formulation Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Injectable Drug Delivery Formulation Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Injectable Drug Delivery Formulation Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Injectable Drug Delivery Formulation Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Injectable Drug Delivery Formulation Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Injectable Drug Delivery Formulation Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Injectable Drug Delivery Formulation Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Injectable Drug Delivery Formulation Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Injectable Drug Delivery Formulation Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Injectable Drug Delivery Formulation Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Injectable Drug Delivery Formulation Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Injectable Drug Delivery Formulation Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Injectable Drug Delivery Formulation Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Injectable Drug Delivery Formulation Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Injectable Drug Delivery Formulation Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Injectable Drug Delivery Formulation Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Injectable Drug Delivery Formulation Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Injectable Drug Delivery Formulation Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Injectable Drug Delivery Formulation Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Injectable Drug Delivery Formulation Typical Distributors
Table 101. Injectable Drug Delivery Formulation Typical Customers
List of Figures
Figure 1. Injectable Drug Delivery Formulation Picture
Figure 2. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 3. Conventional Drug Delivery Formulations
Figure 4. Novel Drug Delivery Formulations
Figure 5. Long-acting Formulations
Figure 6. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 7. Autoimmune Diseases
Figure 8. Hormonal Disorders
Figure 9. Oncology
Figure 10. Orphan Diseases
Figure 11. Others
Figure 12. Global Injectable Drug Delivery Formulation Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Injectable Drug Delivery Formulation Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Injectable Drug Delivery Formulation Sales (2016-2026) & (K Pcs)
Figure 15. Global Injectable Drug Delivery Formulation Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Injectable Drug Delivery Formulation Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Injectable Drug Delivery Formulation Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Injectable Drug Delivery Formulation Market Drivers
Figure 19. Injectable Drug Delivery Formulation Market Restraints
Figure 20. Injectable Drug Delivery Formulation Market Trends
Figure 21. Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturer in 2020
Figure 22. Global Injectable Drug Delivery Formulation Revenue Market Share by Manufacturer in 2020
Figure 23. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Injectable Drug Delivery Formulation Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Injectable Drug Delivery Formulation Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2026)
Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2016-2026)
Figure 28. North America Injectable Drug Delivery Formulation Revenue (2016-2026) & (USD Million)
Figure 29. Europe Injectable Drug Delivery Formulation Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Injectable Drug Delivery Formulation Revenue (2016-2026) & (USD Million)
Figure 31. South America Injectable Drug Delivery Formulation Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Injectable Drug Delivery Formulation Revenue (2016-2026) & (USD Million)
Figure 33. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2026)
Figure 34. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2016-2026)
Figure 35. Global Injectable Drug Delivery Formulation Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 37. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2016-2026)
Figure 38. Global Injectable Drug Delivery Formulation Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2026)
Figure 40. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 41. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2026)
Figure 42. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2026)
Figure 43. United States Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2026)
Figure 47. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 48. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2026)
Figure 49. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2026)
Figure 50. Germany Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region (2016-2026)
Figure 59. China Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2026)
Figure 66. South America Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 67. South America Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2026)
Figure 68. South America Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Injectable Drug Delivery Formulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の皮下ドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 世界の医薬品ドラッグデリバリー市場 2021：企業別、地域別、種類・用途別 The Pharmaceutical Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の医薬品ドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Pharmaceutical Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の医薬品ドラッグデリバリー技術市場 2021：企業別、地域別、種類・用途別 The Pharmaceutical Drug Delivery Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の単位用量ドラッグデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Unit Dose Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…